UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 533

Sortiert nach

NAFLD: A multisystem disease

Journal of hepatology, 2015-04, Vol.62 (1), p.S47-S64

2015

Link zum Volltext

Verfügbarkeit prüfen

Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: A meta-analysis

Journal of hepatology, 2016-09, Vol.65 (3), p.589-600

2016

Link zum Volltext

Verfügbarkeit prüfen

Nonalcoholic Fatty Liver Disease: A Novel Cardiometabolic Risk Factor for Type 2 Diabetes and Its Complications

The journal of clinical endocrinology and metabolism, 2013-02, Vol.98 (2), p.483-495

2013

Link zum Volltext

Verfügbarkeit prüfen

Nonalcoholic Fatty Liver Disease in Children

Seminars in liver disease, 2018-02, Vol.38 (1), p.1

2018

Link zum Volltext

Verfügbarkeit prüfen

Ectopic fat, insulin resistance, and nonalcoholic fatty liver disease: implications for cardiovascular disease

Arteriosclerosis, thrombosis, and vascular biology, 2014-06, Vol.34 (6), p.1155

2014

Link zum Volltext

Verfügbarkeit prüfen

EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease: is universal screening appropriate?

Diabetologia, 2016-06, Vol.59 (6), p.1141-1144

2016

Link zum Volltext

Verfügbarkeit prüfen

Ectopic fat, insulin resistance and non-alcoholic fatty liver disease

Proceedings of the Nutrition Society, 2013-11, Vol.72 (4), p.412-419

Byrne, Christopher D.

2013

Link zum Volltext

Verfügbarkeit prüfen

A single-letter change in an acronym: signals, reasons, promises, challenges, and steps ahead for moving from NAFLD to MAFLD

Expert review of gastroenterology & hepatology, 2021-04, Vol.15 (4), p.345-352

2021

Link zum Volltext

Verfügbarkeit prüfen

Circulating Markers of Liver Function and Cardiovascular Disease Risk

Arteriosclerosis, thrombosis, and vascular biology, 2015-11, Vol.35 (11), p.2290

2015

Link zum Volltext

Verfügbarkeit prüfen

Diagnosis and management of nonalcoholic fatty liver disease and its hemostatic/thrombotic and vascular complications

Seminars in thrombosis and hemostasis, 2013-03, Vol.39 (2), p.214

2013

Link zum Volltext

Verfügbarkeit prüfen

Non-alcoholic fatty liver disease: a new and important cardiovascular risk factor?

European heart journal, 2012-05, Vol.33 (10), p.1190-1200

2012

Link zum Volltext

Verfügbarkeit prüfen

Alcohol consumption and metabolic syndrome: Clinical and epidemiological impact on liver disease

Journal of hepatology, 2023-01, Vol.78 (1), p.191-206

2023

Link zum Volltext

Verfügbarkeit prüfen

Resolution of Fatty Liver and Risk of Incident Diabetes

The journal of clinical endocrinology and metabolism, 2013-09, Vol.98 (9), p.3637-3643

2013

Link zum Volltext

Verfügbarkeit prüfen

Obesity Is a Risk Factor for Greater COVID-19 Severity

Diabetes care, 2020-07, Vol.43 (7), p.e72-e74

2020

Link zum Volltext

Verfügbarkeit prüfen

Serum uric acid concentrations and fructose consumption are independently associated with NASH in children and adolescents

Journal of hepatology, 2017-05, Vol.66 (5), p.1031-1036

2017

Link zum Volltext

Verfügbarkeit prüfen

Obesity: Metabolically healthy obesity and NAFLD

Nature reviews. Gastroenterology & hepatology, 2016-08, Vol.13 (8), p.442

2016

Link zum Volltext

Verfügbarkeit prüfen

NAFLD improves risk prediction of type 2 diabetes: with effect modification by sex and menopausal status

Hepatology (Baltimore, Md.), 2022-12, Vol.76 (6), p.1755-1765

2022

Link zum Volltext

Verfügbarkeit prüfen

Development of new fatty liver, or resolution of existing fatty liver, over five years of follow-up, and risk of incident hypertension

Journal of hepatology, 2014-05, Vol.60 (5), p.1040-1045

2014

Link zum Volltext

Verfügbarkeit prüfen

Effect of exercise on the development of new fatty liver and the resolution of existing fatty liver

Journal of hepatology, 2016-10, Vol.65 (4), p.791-797

2016

Link zum Volltext

Verfügbarkeit prüfen

History of Gestational Diabetes and Incident Nonalcoholic Fatty Liver Disease: The Kangbuk Samsung Health Study

The American journal of gastroenterology, 2023-11, Vol.118 (11), p.1980-1988

2023

Link zum Volltext

Verfügbarkeit prüfen

Total colonic mucocoele following ultra‐low anterior resection for mid‐rectal cancer

ANZ journal of surgery, 2022-05, Vol.92 (5), p.1255-1256

2022

Link zum Volltext

Verfügbarkeit prüfen

Why are there no strategies for NAFLD?

Journal of hepatology, 2022-04, Vol.76 (4), p.763-764

2022

Link zum Volltext

Verfügbarkeit prüfen

Extrapulmonary complications of COVID‐19: A multisystem disease?

Journal of medical virology, 2021-01, Vol.93 (1), p.323-335

2021

Link zum Volltext

Verfügbarkeit prüfen

Heterogeneity of white adipocytes in metabolic disease

Current opinion in clinical nutrition and metabolic care, 2023-03, Vol.26 (2), p.72

2023

Link zum Volltext

Verfügbarkeit prüfen

Reply: NAFLD improves risk prediction of type 2 diabetes-With effect modification by sex and menopausal status

Hepatology (Baltimore, Md.), 2024-02, Vol.79 (2), p.E20-E21

2024

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 533

Suche als RSS-Feed

Aktive Filter

ThemaLiver Diseases

KollektionWK Lippincott Williams & Wilkins–Connect here FIRST to enable access

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(512)
Mit Volltextzugriff
(442)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

NAFLD: A multisystem disease

Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: A meta-analysis

Nonalcoholic Fatty Liver Disease: A Novel Cardiometabolic Risk Factor for Type 2 Diabetes and Its Complications

Nonalcoholic Fatty Liver Disease in Children

Ectopic fat, insulin resistance, and nonalcoholic fatty liver disease: implications for cardiovascular disease

EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease: is universal screening appropriate?

Ectopic fat, insulin resistance and non-alcoholic fatty liver disease

A single-letter change in an acronym: signals, reasons, promises, challenges, and steps ahead for moving from NAFLD to MAFLD

Circulating Markers of Liver Function and Cardiovascular Disease Risk

Diagnosis and management of nonalcoholic fatty liver disease and its hemostatic/thrombotic and vascular complications

Non-alcoholic fatty liver disease: a new and important cardiovascular risk factor?

Alcohol consumption and metabolic syndrome: Clinical and epidemiological impact on liver disease

Resolution of Fatty Liver and Risk of Incident Diabetes

Obesity Is a Risk Factor for Greater COVID-19 Severity

Serum uric acid concentrations and fructose consumption are independently associated with NASH in children and adolescents

Obesity: Metabolically healthy obesity and NAFLD

NAFLD improves risk prediction of type 2 diabetes: with effect modification by sex and menopausal status

Development of new fatty liver, or resolution of existing fatty liver, over five years of follow-up, and risk of incident hypertension

Effect of exercise on the development of new fatty liver and the resolution of existing fatty liver

History of Gestational Diabetes and Incident Nonalcoholic Fatty Liver Disease: The Kangbuk Samsung Health Study

Total colonic mucocoele following ultra‐low anterior resection for mid‐rectal cancer

Why are there no strategies for NAFLD?

Extrapulmonary complications of COVID‐19: A multisystem disease?

Heterogeneity of white adipocytes in metabolic disease

Reply: NAFLD improves risk prediction of type 2 diabetes-With effect modification by sex and menopausal status

Aktive Filter

Suchergebnisse filtern